Trial intelligence / Profile preview

Loading-dose atorvastatin before elective PCI in STEMI

ChiCTR-IPR-15006785Phase 4Recruiting

Sponsor
Wuhan Asia Heart Hospital
Start
Aug 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of atorvastatin in myocardial infarction (MI) (2 arms), sponsored by Wuhan Asia Heart Hospital. Primary endpoint: Cytokines. Started Aug 2013; status: recruiting.

02

Drugs

atorvastatin
03

Conditions

myocardial infarction (MI)

Beyond the preview

Go deeper on ChiCTR-IPR-15006785.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-IPR-15006785.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call